CHOP treatment of childhood acute myelogenous leukemia with monocytic differentiation: a report on five cases.
Five children with M4 or M5 acute myelogenous leukemia (AML) not responding to previous treatment or in relapse were treated with a four-drug protocol consisting of cyclophosphamide, adriamycin, vincristine, prednisone, and CNS prophylaxis. There were two treatment failures; the remaining three patients have achieved complete remission, lasting 18+, 13+, and 12+ months respectively. Further follow-up is to be performed.